Venus Remedies Limited

VENUSREM.BO·BSE·Healthcare
Compare
1,454.15+69.20 (+5.00%)today
At close: Nov 5, 3:27 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,384.95
Open1,440.00
Day range1,438.001,454.15
52-week range439.102,043.15
Off day high0.00%
Off 52-week high−28.83%
Volume3.26K
Avg. volume (3M)3.89K
Market cap19.44B
EPS (TTM)91.04
Forward P/E—
P/E ratio (TTM)15.97
Dividend yield0.72% (10.00)
Beta (5Y)0.45
Shares outstanding13.37M
Short interest—
Earnings dateMay 26, 2025
Analyst target—
Profit margin14.53%

Against its peers

Compare in full ›
VENUSREM.BO SOLARA.NS 1795.TW RPGLIFE.NS MEDICO.NS INDSWFTLAB.BO
Market cap 19.44B 31.04B 44.76B 42.93B 1.53B 31.50B
P/E (TTM) 16.0 83.4 11.8 38.7 11.0 37.0
Forward P/E — 20.5 7.1 27.6 — —
Price/book 2.8 2.2 1.9 7.1 2.0 2.1
Dividend yield 0.72% — 1.61% 0.92% — —
1-year change +213.27% +14.61% −42.88% +6.05% −62.84% +268.15%
Today +5.00% −0.25% +5.66% −0.11% −0.59% −4.09%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

SAHI··3 outletsPositive

Venus Remedies Receives Five Marketing Approvals In Kazakhstan, Peru, Kuwait, Argentina

Market snapshot: Venus Remedies Limited has secured five new marketing authorisations spanning international markets in Central Asia, Latin America, and the Middle East. The drug approvals encompass key critical care and oncology products…

More from 2 other outlets
BioTecNika·Positive

Freshers Biotechnology Jobs at Venus Remedies | Apply Now

Venus Remedies Limited is a prominent pharmaceutical company based in India, specializing in research and development in the field of pharmacology and toxicology. The organization is dedicated to advancing healthcare solutions and is known…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
8with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance